# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Cantor Fitzgerald analyst Sarah James reiterates CVS Health (NYSE:CVS) with a Neutral and maintains $58 price target.
Humira maintains over 80% of its market share despite facing nine biosimilar rivals, raising concerns about the future of the b...
CVS Health currently has a dividend yield of 4.38%, which is a quarterly dividend amount of 66.5 cents a share ($2.66 a year).